The importance of 1,2,4-triazole derivatives in modern pharmaceuticals is very high. They find their application in drug therapy as antifungal, antifungal agents (fluconazole, intraconazole). It is worth noting that some 1,2,4-triazole compounds are used in therapy for the treatment of Alzheimer's disease, and new, more effective pharmacophores are being sought to create drugs for neurodegenerative diseases. We have proposed a modernized method for obtaining a new bis(1,2,4-triazole) derivative using the recyclization reaction of 4-hydroxy-2,5-disubstituted-1,3-6H-oxazin-6-ones with a bisnucleophilic reagent, which was m-phenylenedihydrazine. The method of preparation described in the literature did not lead to the expected products, so it was necessary to select new reaction conditions. 1,1′-(benzene-1,3-diyl)bis[5-benzyl-3-(4-nitrophenyl)-1H-1,2,4-triazole] was obtained by recyclization of 4-hydroxy-2-(4-nitrophenyl)-5-phenyl-6H-1,3-oxazin-6-one with m-phenylenedihydrazine dihydrochloride in absolute methanol in the presence of sodium methoxide for 48 hours. The structure of the compound was confirmed by 1H, 13C NMR spectroscopy and mass spectrometry. Antifungal and antibacterial activities were determined by serial dilutions using meat-peptone broth and Sabouraud medium. The yield based on 4-hydroxy-2-(4-nitrophenyl)-5-phenyl-6H-1,3-oxazin-6-one was 76%. The obtained compound exhibits antimicrobial activity against Staphylococcus aureus with a minimum inhibitory concentration of 62.5 μg/ml and 125 μg/ml against Candida albicans.